Publikationen, an denen er mitarbeitet José Pablo Lara Muñoz (1)

2022

  1. Reply to: Comment on: Clinical benefits of empagliflozin in very old patients with type 2 diabetes hospitalized for acute heart failure

    Journal of the American Geriatrics Society